Cite
APA Citation
Correll, C. U., Miller, A. C., Sawchak, S., Kaul, I., Paul, S. M., & Brannan, S. K. (2023). safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial. CNS spectrums, 28, 220. http://access.bl.uk/ark:/81055/vdc_100184055734.0x00002b